NHS
The quiet crisis: why medicines operations matter more than ever in the ICB era
July 4, 2025Business Services, Market Access Gateway to Local Adoption, Integrated Care Board, NHS, Primary Care Networks, Visions4Health
In the second of the Gateway to Local Access series, Vision4Health caught up with Dr Graham Duce, ICB GP Prescribing …
Unlocking the gateway to ‘precision’ UK market access
June 27, 2025Business Services, Market Access, Market Access Consultancy, Sales and Marketing NHS, Visions4Health
As the UK healthcare system navigates a period of significant change, the path to successful market access is becoming increasingly …
NICE recommends spevigo for rare and severe psoriasis flares
June 20, 2025Medical Communications, Research and Development Dermatology, NHS, National Institute for Health and Care Excellence, generalised pustular psoriasis
The National Institute for Health and Care Excellence (NICE) has recommended Spevigo (spesolimab) for the treatment of generalised pustular psoriasis …
NICE recommends Pfizer’s new once-weekly treatment for haemophilia B on NHS
May 22, 2025Market Access, Research and Development Haematology, Hympavzi, NHS, NICE, Pfizer, haemophilia B, marstacimab
Walton Oaks, 21st May 2025 – Pfizer Ltd announced today that the National Institute for Health and Care Excellence (NICE) has published final …
Cervical cancer experts campaign to increase screening rates and save lives
April 30, 2025Research and Development NHS, NHS England, Oncology, campaign, cervical cancer, screening
A coalition of experts fighting to end cervical cancer, referred to as the UK Consensus Group of the Advancing Cervical …
West Middlesex Hospital goes live with tech to reduce prescribing errors
April 10, 2025Information Technology, Manufacturing and Production Dosium, NHS, Paediatrics, West Middlesex Hospital
Dosium Touchdose has gone live at West Middlesex University Hospital, UK, a clinical decision support technology proven to significantly reduce …
Takeda announces launch of Framework to help support patient access to life-extending combination treatments
February 25, 2025Business Services Cancer, HIV/AIDS, Immunology, NHS, NICE, Oncology, Takeda, VPAG, patient access
The Conceptual Implementation Framework outlines critical points within the UK healthcare access ecosystem to help improve the introduction of combination …
Inizio Engage and Nye Health form a strategic alliance to enhance patient support and outcomes
August 1, 2024Research and Development Contraception, Inizio Engage, NHS, Nye Health, alliance, data, patient data, patient experience, support
Nye Health’s digital platform will be coupled with the patient support experience available at Inizio Engage. The integrated approach will …
NHS accepts Pfizer’s tafamidis for ATTR-CM treatment
May 14, 2024Medical Communications ATTR-CM, Cardiology, NHS, Pfizer, tafamidis
NHS England has announced that it has accepted Pfizer’s drug, tafamidis, for the treatment of transthyretin amyloidosis cardiomyopathy (ATTR-CM).
NICE recommends migraine treatment for NHS use
April 11, 2024Medical Communications NHS, NICE, Neurology, migraine
The National Institute for Health and Care Excellence (NICE) has shared draft guidance recommending AbbVie’s Aquipta (atogepant) as an option …
Novo Nordisk launches Wegovy in the UK
September 4, 2023Medical Communications NHS, NICE, Novo Nordisk, Obesity, Wegovy, weight loss
Novo Nordisk has today announced that Wegovy (semaglutide injection) is now available in the UK through a controlled and limited …
Bristol Myers Squibb’s Sotyktu recommended for NHS use for adult patients with psoriasis
June 28, 2023Medical Communications Dermatology, NHS, Sotyktu, bristol myers squibb, psoriasis
Bristol Myers Squibb (BMS) has announced that the National Institute for Health and Care Excellence (NICE) has recommended Sotyktu (deucravacitinib) …
UK plans £40m drug trial for Novo Nordisk’s Wegovy to aid NHS in treating obesity
June 7, 2023Research and Development NHS, Novo Nordisk, Obesity, Wegovy, clinical trial, obesity
The UK Government has announced plans to launch a pilot programme which will provide GPs with Novo Nordisk’s Wegovy (semaglutide), …
Report finds NHS may miss out on new drugs due to rising costs
June 5, 2023Sales and Marketing LSE, LSHTM, NHS, Pharmacy, University of York, drug prices
Figures from a team at the University of York, the London School of Economics and Political Science (LSE) and the …
NICE approves first treatment for obstructive HCM for NHS use
June 2, 2023Medical Communications Bristol-Myers Squibb, Cardiology, NHS, NICE, obstructive HCM
The National Institute for Health and Care Excellence (NICE) has announced that it has approved mavacamten (Camzyos) for the treatment …
